Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
D000200:Action Potentials / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000758:Anesthesia; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D004837:Epinephrine; D005260:Female; D008297:Male; D009281:Naphthalenes / Q000627:therapeutic use*; D010042:Ouabain; D011433:Propranolol / Q000627:therapeutic use; D012584:Sciatic Nerve / Q000187:drug effects; D012849:Sinoatrial Node / Q000187:drug effects; D013565:Sympatholytics / Q000627:therapeutic use*; D013610:Tachycardia / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D009281:Naphthalenes; D013565:Sympatholytics; D010042:Ouabain; D011433:Propranolol; D004837:Epinephrine